Standard BioTools (LAB) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.08 per share a year ago. These figures are adjusted ...

Since Galileo's time, politicians and ideologues have always tried to interfere with science. It's worse than ever today.

Rocket Lab reports second-quarter revenue of $144.5 million, beating the consensus estimate of $134.53 million. The end-to-end space company reports a second-quarter loss of 13 cents per share, ...

Rocket Lab reports first-quarter revenue of $122.57 million, beating the consensus estimate of $121.38 million. Rocket Lab reports a first-quarter loss of 12 cents per share, beating analyst estimates ...

When people picture a scientist in their head, they conjure an image of a person in a white lab coat, but why do scientists ...